David Findlay Selected Research

Neoplasms (Cancer)

1/2017

Adoptive transfer of ex vivo expanded Vγ9Vδ2 T cells in combination with zoledronic acid inhibits cancer growth and limits osteolysis in a murine model of osteolytic breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David Findlay Research Topics

Disease

4	Alzheimer Disease (Alzheimer's Disease) 12/2017 - 07/2009
2	COVID-19 11/2022 - 11/2021
2	Pain (Aches) 01/2019 - 12/2005
2	Osteolysis 01/2017 - 07/2003
2	Dementia (Dementias) 12/2015 - 07/2009
2	Inflammation (Inflammations) 03/2015 - 07/2012
2	Infections 03/2015 - 07/2012
2	Postmenopausal Osteoporosis 11/2004 - 10/2002
1	Hypersensitivity (Allergy) 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 01/2019
1	Neoplasms (Cancer) 01/2017
1	Breast Neoplasms (Breast Cancer) 01/2017

Drug/Important Bio-Agent (IBA)

4	Donepezil (Aricept)FDA LinkGeneric 12/2017 - 07/2009
4	Memantine (Namenda)FDA Link 12/2017 - 07/2009
2	Viral RNAIBA 11/2022 - 11/2021
2	WastewaterIBA 11/2022 - 11/2021
2	Raloxifene Hydrochloride (Evista)FDA Link 11/2004 - 10/2002
2	Diphosphonates (Bisphosphonates)IBA 11/2004 - 10/2002
1	RNA (Ribonucleic Acid)IBA 11/2021
1	Tartrate-Resistant Acid PhosphataseIBA 01/2019
1	Netrin-1IBA 01/2019
1	DCC ReceptorIBA 01/2019
1	Alendronate (Alendronate Sodium)FDA LinkGeneric 01/2019
1	RANK LigandIBA 01/2019
1	Zoledronic Acid (Zometa)FDA Link 01/2017
1	Trinitrotoluene (TNT)IBA 07/2012
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 03/2012
1	MetalsIBA 07/2003

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 12/2017 - 12/2005
2	Therapeutics 03/2015 - 07/2012
1	Home Nursing (Nursing, Home) 12/2015
1	Institutionalization (Institutionalized Persons) 07/2009